Results of up to 2 years of entecavir vs lamivudine therapy in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B

T. T. Chang, Y. C. Chao, V. V. Gorbakov, K. H. Han, R. G. Gish, R. De Man, H. Cheinquer, F. Bessone, H. Brett-Smith, R. Tamez

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)

Fingerprint Dive into the research topics of 'Results of up to 2 years of entecavir vs lamivudine therapy in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B'. Together they form a unique fingerprint.

Medicine & Life Sciences